BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28852530)

  • 21. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal and neonatal outcomes following a proactive peripartum multidisciplinary management protocol for placenta creta spectrum as compared to the urgent delivery.
    Stanleigh J; Michaeli J; Armon S; Khatib F; Zuckerman B; Shaya M; Ioscovitch A; Shenfeld O; Greenblat D; Farkash R; Tevet A; Samueloff A; Grisaru Granovsky S
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():139-144. PubMed ID: 31039488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time.
    Shamshirsaz AA; Fox KA; Erfani H; Clark SL; Salmanian B; Baker BW; Coburn M; Shamshirsaz AA; Bateni ZH; Espinoza J; Nassr AA; Popek EJ; Hui SK; Teruya J; Tung CS; Jones JA; Rac M; Dildy GA; Belfort MA
    Am J Obstet Gynecol; 2017 Jun; 216(6):612.e1-612.e5. PubMed ID: 28213059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative management versus cesarean hysterectomy in patients with placenta increta or percreta.
    Wang Q; Ma J; Zhang H; Dou R; Huang B; Wang X; Zhao X; Chen D; Ding Y; Ding H; Cui S; Zhang W; Xin H; Gu W; Hu Y; Ding G; Qi H; Fan L; Ma Y; Lu J; Yang Y; Lin L; Luo X; Zhang X; Fan S; Yang H
    J Matern Fetal Neonatal Med; 2022 May; 35(10):1944-1950. PubMed ID: 32498575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Planned conservative management of placenta increta and percreta with prophylactic transcatheter arterial embolization and leaving placenta in situ for women who desire fertility preservation.
    Huang KL; Leung-Chit Tsang L; Cheng YF; Huang FJ; Fu HC; Kung FT; Tsai CC; Cheng HH; Lai YJ; Ou CY; Chen WT; Tong YS; Chen YC; Huang YJ; Hsu TY
    Placenta; 2020 Aug; 97():51-57. PubMed ID: 32792063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis.
    Markley JC; Farber MK; Perlman NC; Carusi DA
    Anesth Analg; 2018 Oct; 127(4):930-938. PubMed ID: 29481427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An alternate surgical approach to reduce hemorrhage and complications during cesarean hysterectomy for adherent placenta.
    Saha PK; Bagga R; Kalra JK; Arora A; Singla R; Suri V; Jain K; Kumar P; Gupta N; Jain A; Singh T; Mavuduru RS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():215-220. PubMed ID: 30007249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta.
    Pan Y; Zhou X; Yang Z; Cui S; De W; Sun L
    Int J Gynaecol Obstet; 2017 Apr; 137(1):45-50. PubMed ID: 28098341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal outcome after conservative management of abnormally invasive placenta.
    Su HW; Yi YC; Tseng JJ; Chen WC; Chen YF; Kung HF; Chou MM
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):353-357. PubMed ID: 28600047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular balloon occlusion and planned caesarean hysterectomy for morbidly adherent placenta: A systematic review.
    Makary M; Chowdary P; Westgate JA
    Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):608-615. PubMed ID: 31281966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic intraoperative uterine artery embolization to control hemorrhage in abnormal placentation during late gestation.
    Yu PC; Ou HY; Tsang LL; Kung FT; Hsu TY; Cheng YF
    Fertil Steril; 2009 May; 91(5):1951-5. PubMed ID: 18501901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of peripartum hysterectomies performed on patients with placenta percreta in a tertiary central hospital.
    Sak S; Barut M; Incebiyik A; Uyanikoglu H; Hilali N; Sak M
    J Matern Fetal Neonatal Med; 2019 Mar; 32(6):883-888. PubMed ID: 29096564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta.
    Teixidor Viñas M; Chandraharan E; Moneta MV; Belli AM
    Clin Radiol; 2014 Aug; 69(8):e345-51. PubMed ID: 24880757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative management of placenta percreta.
    Matsuzaki S; Yoshino K; Endo M; Kakigano A; Takiuchi T; Kimura T
    Int J Gynaecol Obstet; 2018 Mar; 140(3):299-306. PubMed ID: 29194646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis, treatment and application of color Doppler in conservative management of abnormally adherent placenta.
    Merz W; Van de Vondel P; Strunk H; Geipel A; Gembruch U
    Ultraschall Med; 2009 Dec; 30(6):571-6. PubMed ID: 18773385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Standardized Approach for Transfusion Medicine Support in Patients With Morbidly Adherent Placenta.
    Panigrahi AK; Yeaton-Massey A; Bakhtary S; Andrews J; Lyell DJ; Butwick AJ; Goodnough LT
    Anesth Analg; 2017 Aug; 125(2):603-608. PubMed ID: 28640786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of cervical lifting suture in hemostasis of placenta previa with increta and percreta].
    Chen YS; Zhao YY; Zhang Y; Wang Y; Zhong YW; Zhang AQ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):459-463. PubMed ID: 30078255
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgical management of 58 patients with placenta praevia percreta.
    Camuzcuoglu A; Vural M; Hilali NG; Incebiyik A; Yuce HH; Kucuk A; Camuzcuoglu H
    Wien Klin Wochenschr; 2016 May; 128(9-10):360-6. PubMed ID: 26913862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.
    Yasin N; Slade L; Atkinson E; Kennedy-Andrews S; Scroggs S; Grivell R
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):550-554. PubMed ID: 30565213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination by year of cases applied with caesarean hysterectomy because of placenta percreta in a tertiary centre: a retrospective cohort study.
    Bakacak Z; Bakacak M; Güzin K; Yazar FM; Yaylalı A; Uzkar A
    Ginekol Pol; 2021; 92(4):284-288. PubMed ID: 33751513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.